# EDGAR Filing Document

**Accession Number:** 0001465314
**File Stem:** 0001596783-23-000013
**Filing Date:** 2023-2
**Character Count:** 6114
**Document Hash:** 3a2b82de1dd2e9b6dc17a2056d01fcf1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001596783-23-000013.hdr.sgml**: 20230206

**ACCESSION NUMBER**: 0001596783-23-000013

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230125

**FILED AS OF DATE**: 20230206

**DATE AS OF CHANGE**: 20230206

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Zayas Ricardo
- **CENTRAL INDEX KEY:** 0001465314

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36587
- **FILM NUMBER:** 23592187

**MAIL ADDRESS:**
- **STREET 1:** 100 HAYDEN AVENUE
- **CITY:** LEXINGTON
- **STATE:** MA
- **ZIP:** 02421
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Catalent, Inc.
- **CENTRAL INDEX KEY:** 0001596783
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 208737688
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0630

**BUSINESS ADDRESS:**
- **STREET 1:** 14 SCHOOLHOUSE ROAD
- **CITY:** SOMERSET
- **STATE:** NJ
- **ZIP:** 08873
- **BUSINESS PHONE:** (732) 537-6200

**MAIL ADDRESS:**
- **STREET 1:** 14 SCHOOLHOUSE ROAD
- **CITY:** SOMERSET
- **STATE:** NJ
- **ZIP:** 08873

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PTS Holdings Corp.
- **DATE OF NAME CHANGE:** 20140113

## Ex-24

```
<pre>
POWER OF ATTORNEY

Know all by these presents that the undersigned does hereby make, constitute,
and appoint each of Steven Fasman, Amy Fallone, and Eve Dyatlova, or any one of them, as a true and lawful attorney-in-fact of the undersigned, with full powers of substitution and revocation, for and in the name, place, and stead of the undersigned (in the undersigned's individual capacity) to execute and deliver such forms that the undersigned may be required to file with the U.S. Securities and Exchange Commission as a result of the undersigned's ownership of or transactions in securities of Catalent, Inc. (i) pursuant to Section 16(a) of the Securities Exchange Act of 1934, as amended ("Section 16"), including without limitation statements on Form 3, Form 4, and Form 5, and any amendments thereto; and (ii) in connection with any applications for EDGAR access codes, including without limitation the Form ID. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to make filings pursuant to Section 16 with regard to the undersigned's ownership of or transactions in securities of Catalent, Inc., unless earlier revoked in writing. The undersigned acknowledges that Steven Fasman, Amy Fallone, and Eve Dyatlova are not assuming any of the undersigned's responsibilities to comply with Section 16.

/s/ Ricardo Zayas
----------------------------------
Ricardo Zayas

Date:    January 26, 2023
</pre>
```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Zayas Ricardo<br><sub>(Last) (First) (Middle)</sub><br>C/O CATALENT, INC.<br>14 SCHOOLHOUSE ROAD<br><sub>(Street)</sub><br>SOMERSET, NJ 08873<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Catalent, Inc. [ CTLT ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-01-25 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_SVP, Operations, Biologics NA_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 1788<sup>(1)</sup> | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Options to purchase Common Stock | <sup>(2)</sup> | 2033-01-23 | Common Stock | 6680.0 | $52.59 | D |  |

---

### Footnotes:

(1) Restricted stock units, each representing the right to receive one share of the Issuer's common stock as of the date of vesting, which is scheduled to occur on January 23, 2026.

(2) Options are scheduled to vest and become exercisable in four equal annual installments beginning on January 23, 2024.

**Remarks:**
EXHIBIT LIST: EX-24 Ricardo Zayas POA

**Signature:** /s/ Amy Fallone, attorney-in-fact  
**Date:** 2023-02-06

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**